Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 459

1.

The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling.

van Tok MN, Na S, Lao CR, Alvi M, Pots D, van de Sande MGH, Taurog JD, Sedgwick JD, Baeten DL, van Duivenvoorde LM.

Front Immunol. 2018 Jul 9;9:1550. doi: 10.3389/fimmu.2018.01550. eCollection 2018.

2.

The role of IL-23/IL-17 axis in human kidney allograft rejection.

Haouami Y, Dhaouadi T, Sfar I, Bacha M, Gargah T, Bardi R, Abderrahim E, Goucha R, Ben Abdallah T, Gorgi Y.

J Leukoc Biol. 2018 Jul 19. doi: 10.1002/JLB.5AB0318-148R. [Epub ahead of print]

PMID:
30024651
3.

Act1 is a negative regulator in T and B cells via direct inhibition of STAT3.

Zhang CJ, Wang C, Jiang M, Gu C, Xiao J, Chen X, Martin BN, Tang F, Yamamoto E, Xian Y, Wang H, Li F, Sartor RB, Smith H, Husni ME, Shi FD, Gao J, Carman J, Dongre A, McKarns SC, Coppieters K, Jørgensen TN, Leonard WJ, Li X.

Nat Commun. 2018 Jul 16;9(1):2745. doi: 10.1038/s41467-018-04974-3.

4.

IL-17 and IL-22 production in HIV+ individuals with latent and active tuberculosis.

Devalraju KP, Neela VSK, Ramaseri SS, Chaudhury A, Van A, Krovvidi SS, Vankayalapati R, Valluri VL.

BMC Infect Dis. 2018 Jul 11;18(1):321. doi: 10.1186/s12879-018-3236-0.

5.

p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin.

Škrlec K, Zadravec P, Hlavničková M, Kuchař M, Vaňková L, Petroková H, Křížová L, Černý J, Berlec A, Malý P.

Int J Mol Sci. 2018 Jul 1;19(7). pii: E1933. doi: 10.3390/ijms19071933.

6.

Complex role of IL-23R polymorphisms on ankylosing spondylitis: a meta-analysis.

Zhong L, Wang W, Song H.

Expert Rev Clin Immunol. 2018 Jul;14(7):635-643. doi: 10.1080/1744666X.2018.1491308. Epub 2018 Jul 3.

PMID:
29944013
7.

Targeting Inflammatory T Helper Cells via Retinoic Acid-Related Orphan Receptor Gamma t Is Ineffective to Prevent Allo-Response-Driven Colitis.

Buchele V, Abendroth B, Büttner-Herold M, Vogler T, Rothamer J, Ghimire S, Ullrich E, Holler E, Neurath MF, Hildner K.

Front Immunol. 2018 May 25;9:1138. doi: 10.3389/fimmu.2018.01138. eCollection 2018.

8.

A safety evaluation of guselkumab for the treatment of psoriasis.

Galluzzo M, D'Adamio S, Campione E, Bianchi L, Talamonti M.

Expert Opin Drug Saf. 2018 Jul;17(7):741-751. doi: 10.1080/14740338.2018.1488963. Epub 2018 Jul 4. Review.

PMID:
29897790
9.

Increased Expression of IL-23 Receptor (IL-23R) in Vogt-Koyanagi-Harada (VKH) Disease.

Wang C, Wang L, Hu J, Li H, Kijlstra A, Yang P.

Curr Eye Res. 2018 Jun 7:1-5. doi: 10.1080/02713683.2018.1485952. [Epub ahead of print]

PMID:
29877734
10.

Correlations of IL-23R gene polymorphism with clinicopathological characteristics and prognosis of hepatocellular carcinoma patients after interventional therapy.

Pan X, Wang G.

Genomics. 2018 Jun 1. pii: S0888-7543(18)30293-3. doi: 10.1016/j.ygeno.2018.05.023. [Epub ahead of print]

PMID:
29864461
11.

Synthetic cytokine receptors transmit biological signals using artificial ligands.

Engelowski E, Schneider A, Franke M, Xu H, Clemen R, Lang A, Baran P, Binsch C, Knebel B, Al-Hasani H, Moll JM, Floß DM, Lang PA, Scheller J.

Nat Commun. 2018 May 23;9(1):2034. doi: 10.1038/s41467-018-04454-8.

12.

Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence.

Toussirot E, Béreau M, Vauchy C, Saas P.

Front Physiol. 2018 Apr 24;9:440. doi: 10.3389/fphys.2018.00440. eCollection 2018. Review.

13.

A model of TH17-associated ileal hyperplasia that requires both IL-17A and IFNγ to generate self-tolerance and prevent colitis.

Jeschke JC, Mayne CG, Ziegelbauer J, DeCiantis CL, Singh S, Kumar SN, Suchi M, Iwakura Y, Drobyski WR, Salzman NH, Williams CB.

Mucosal Immunol. 2018 Jul;11(4):1127-1137. doi: 10.1038/s41385-018-0023-6. Epub 2018 May 4.

PMID:
29728642
14.

Distinct characteristics of hippocampal pathogenic TH17 cells in a mouse model of depression.

Beurel E, Lowell JA, Jope RS.

Brain Behav Immun. 2018 Apr 24. pii: S0889-1591(18)30131-4. doi: 10.1016/j.bbi.2018.04.012. [Epub ahead of print]

PMID:
29698707
15.

Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: an updated meta-analysis.

Lee YH, Song GG.

Z Rheumatol. 2018 Apr 24. doi: 10.1007/s00393-018-0472-z. [Epub ahead of print]

PMID:
29691688
16.

Role of IL-23 signaling in the progression of premalignant oral lesions to cancer.

Caughron B, Yang Y, Young MRI.

PLoS One. 2018 Apr 17;13(4):e0196034. doi: 10.1371/journal.pone.0196034. eCollection 2018.

17.

IL-23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice.

Engelbertsen D, Depuydt MAC, Verwilligen RAF, Rattik S, Levinsohn E, Edsfeldt A, Kuperwaser F, Jarolim P, Lichtman AH.

J Am Heart Assoc. 2018 Apr 4;7(8). pii: e008257. doi: 10.1161/JAHA.117.008257.

18.

Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression.

Saito-Sasaki N, Sawada Y, Mashima E, Yamaguchi T, Ohmori S, Yoshioka H, Haruyama S, Okada E, Nakamura M.

Sci Rep. 2018 Apr 3;8(1):5522. doi: 10.1038/s41598-018-23623-9.

19.

Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway.

Xu X, Yang C, Chen J, Liu J, Li P, Shi Y, Yu P.

Biochem Biophys Res Commun. 2018 May 5;499(2):273-278. doi: 10.1016/j.bbrc.2018.03.144. Epub 2018 Mar 24.

PMID:
29574157
20.

Dataset on characterization of recombinant interleukin-23α, IL-12p40 and IL-23 complex protein, which activates JAK-STAT signaling pathway in chicken cell lines using immunocytochemical staining.

Truong AD, Hoang CT, Hong Y, Lee J, Lee K, Lillehoj HS, Hong YH.

Data Brief. 2017 Dec 12;16:799-805. doi: 10.1016/j.dib.2017.12.008. eCollection 2018 Feb.

Supplemental Content

Loading ...
Support Center